WTA mandates genetic testing for all players before 2028 Olympics

The Women's Tennis Association has announced that, effective July 21, all players must undergo a one-time SRY gene test to maintain eligibility for participation in competitions, including the 2028 Los Angeles Olympics. The updated policy comes after a similar mandate from the International Olympic Committee earlier this year. The testing will be administered via blood sample or cheek swab, covered by the WTA. Positive test results will render players ineligible unless they can confirm a medical condition that justifies their status. The WTA has not publicly detailed the reasoning for this policy change or stated whether it consulted with medical professionals or athletes.

• 5:00 PMESPN Tennis — WTA starting gene testing for all players on tour
• 4:10 PMYahoo Sports — WTA mandates genetic testing for all future competitions